查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2085365

持續性腎臟替代療法市場：按產品類型、模式、膜類型、應用和最終用戶分類的全球市場預測，2026-2032年

Continuous Renal Replacement Therapy Market by Product Type, Modality, Membrane Type, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 193 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，連續性腎臟替代療法 (CRRT) 市場將成長至 26.4 億美元，複合年成長率為 7.58%。

主要市場統計數據
基準年 2025 15.8億美元
預計年份：2026年 17億美元
預測年份：2032年 26.4億美元
複合年成長率 (%) 7.58%

開始持續性腎臟替代治療

連續性腎臟替代療法（CRRT）是一種重症監護中的腎功能支持療法，主要用於血流動力學不穩定、體液超負荷、膿毒症或急性腎損傷（AKI）等需要複雜重症監護的患者。與間歇性血液透析不同，CRRT能夠更緩慢、更持續地清除溶質和體液，幫助臨床醫師控制嚴重病患的血壓波動、電解質失衡、酸鹼平衡，並精確維持體液平衡。

重塑 CRRT 前景的變革性變化

在連續性腎臟替代療法（CRRT）領域，採購模式正從以設備為中心轉向腎臟護理和重症監護的一體化生態系統。醫院在評估平台時，不僅關注設備價格，還越來越重視治療柔軟性、抗凝血治療支援、安全警報、濾芯性能、連接性、培訓要求、液體管理、一次性用品的可靠性以及整體擁有成本。

人工智慧對連續性腎臟替代療法的累積影響

人工智慧正透過預測分析、病患病情惡化預警、工作流程自動化和決策支援工具，開始對持續性腎臟替代療法產生影響。這些工具能夠幫助臨床醫生識別急性腎損傷（AKI）風險、體液超負荷趨勢、電解質失衡、抗凝血治療挑戰以及濾器凝血模式。其累積影響並非在於取代臨床判斷，而是提高高風險重症加護病房（ICU）中整個資料流的可視性。

全球CRRT市場關鍵區域洞察

北美地區憑藉其先進的重症監護室基礎設施、腎臟科與重症監護科室之間成熟的合作、完善的膿毒症和急性腎損傷（AKI）管理方案，以及在美國和加拿大各大學醫院的廣泛應用，仍然是CRRT（連續性腎臟替代療法）應用率較高的地區。在歐洲，其優點包括成熟的醫院採購體系、實證重症監護，以及德國、法國、義大利、西班牙和英國等國已建立的腎臟替代療法管道。同時，歐盟醫療設備框架更強調臨床安全、可追溯性、品質系統和上市後監測。

影響 CRRT 需求的關鍵群體洞察

在東協，私立醫院的擴張、醫療旅遊的發展、重症監護投入的增加以及腎病醫療服務可及性的提高，都支撐了對持續性腎臟替代療法的需求，但醫護人員培訓、治療方案標準化以及耗材價格的可承受性仍然是至關重要的因素。在海灣合作理事會（GCC）國家，隨著三級醫療機構、移植和心臟病計畫的擴建、國家醫療現代化策略的實施以及對重症患者監護系統的投入，CRRT（連續性腎臟替代療法）的普及正在加速。

各國關於CRRT實施情況的關鍵見解

美國憑藉大規模的重症監護室網路、學術研究活動、規範化的重症監護流程以及完善的報銷管道，在先進的連續性腎臟替代療法（CRRT）應用方面處於主導。而加拿大則更注重集中採購、省級醫療保健規劃以及醫院系統內醫療資源的公平取得。在墨西哥和巴西，CRRT在都市區三級醫療機構的應用正在不斷擴展，其使用情況受公共和私人資金籌措、訓練有素的重症監護室醫護人員、腎臟病服務的可及性以及穩定的液體、濾器和抗凝劑供應等因素的影響。

CRRT產業領導者使用的實用建議

產業領導者應優先考慮提供全面的CRRT價值提案，該主張應結合可靠的設備、血液濾過器、透析液和置換液、與抗凝血治療的兼容性、數位化連接、安全功能以及系統化的培訓。醫院需要能夠減少治療中斷、簡化護理工作流程、支持方案依從性、提高液體平衡準確性並在高風險環境下保障病人安全的解決方案。

CRRT 情報調查方法

一項全面的CRRT情報評估應結合來自同行評審的腎臟病學和重症監護文獻、監管資料庫、醫院採購揭露、醫療設備通報、臨床指南、公共衛生資料集、報銷標準和技術評估文件的二手研究。初步檢驗應包括與腎臟科醫生、重症監護醫生、ICU護士、採購經理、分銷商、生物醫學工程師、藥劑師和腎臟治療專家的訪談。

結論：連續性腎臟替代療法的未來

隨著醫院擴大收治急性腎損傷（AKI）、敗血症、心臟疾病、創傷、器官移植和多重器官衰竭等複雜病例，持續性腎臟替代療法正成為現代重症監護的重要戰略支柱。雖然在擁有完善的重症監護基礎設施、技術精湛的醫療團隊、報銷體系、成熟規範的治療方案和高效的供應鏈的地區，持續性腎臟替代療法的應用最為廣泛，但在對成本和資源消耗高度敏感的地區，差距依然顯著。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 工業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章：持續殘餘療法市場：依產品類型分類

  • CRRT設備/主機
  • 一次性產品
  • 透析液和置換液

第8章：持續殘餘療法市場：依治療方式分類

  • 血液透析過濾
  • 血液透析
  • 血液過濾
  • 超過濾

第9章：持續殘餘療法市場：以膜類型分類

  • 高血流量動脈
  • 標準助熔劑膜

第10章：持續殘餘療法市場：依應用領域分類

  • 急性腎損傷（AKI）
  • 慢性腎臟病（CKD）
  • 藥物過量和中毒
  • 敗血症和敗血性休克

第11章：持續殘餘療法市場：以最終用戶分類

  • 門診部
  • 醫院
    • 加護病房
    • 腎臟病學

第12章：持續殘餘療法市場：按地區分類

  • 亞太地區
  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 中東
  • 非洲

第13章：持續殘餘療法市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章：持續殘餘療法市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第16章：公司簡介

  • Asahi Kasei Medical Co., Ltd.
  • B. Braun Melsungen AG
  • Baxter International Inc.
  • Bellco Srl
  • Biolight Co., Ltd.
  • BIoTeque Corporation
  • Cytosorbents Corporation
  • Dialco Medical Inc.
  • Fresenius Medical Care AG & Co. KGaA
  • Genrui BIoTech Co., Ltd.
  • Getinge AB
  • Infomed SA
  • Jafron Biomedical Co., Ltd.
  • JMS Co., Ltd.
  • Kawasumi Laboratories, Inc.
  • LivaNova
  • Medica SpA
  • Medtronic plc
  • Mindray Medical International Limited
  • Nikkiso Co., Ltd.
  • Nipro Corporation
  • Outset Medical, Inc.
  • Quanta Dialysis Technologies
  • SWS Hemodialysis Care Co., Ltd.
  • Terumo Corporation
  • Toray Medical Co., Ltd.
Product Code: MRR-433AB1DC293A

The Continuous Renal Replacement Therapy Market is projected to grow by USD 2.64 billion at a CAGR of 7.58% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 1.58 billion
Estimated Year [2026] USD 1.70 billion
Forecast Year [2032] USD 2.64 billion
CAGR (%) 7.58%

Continuous Renal Replacement Therapy Introduction

Continuous Renal Replacement Therapy (CRRT) is a critical-care renal support modality used primarily for patients with acute kidney injury (AKI) who are hemodynamically unstable, fluid overloaded, septic, or receiving complex intensive care. Unlike intermittent hemodialysis, CRRT enables slower, continuous solute and fluid removal, helping clinicians manage unstable blood pressure, electrolyte imbalance, acid-base disorders, and precise fluid balance in high-acuity settings.

Clinical relevance is supported by the sustained burden of AKI, aging populations, rising sepsis incidence, higher cardiac surgery and transplant activity, and broader ICU modernization. Kidney Disease: Improving Global Outcomes (KDIGO) guidance and critical-care practice patterns continue to reinforce individualized renal replacement therapy selection, positioning CRRT as an essential technology category for advanced hospitals, trauma centers, transplant programs, and tertiary care systems.

Transformative Shifts Reshaping the CRRT Landscape

The CRRT landscape is shifting from equipment-centered purchasing toward integrated renal-critical care ecosystems. Hospitals increasingly evaluate platforms based on therapy flexibility, anticoagulation support, safety alarms, cartridge performance, connectivity, training requirements, fluid logistics, disposables reliability, and total cost of ownership rather than machine price alone.

Clinical practice is also moving toward earlier recognition of AKI risk, standardized ICU protocols, and multidisciplinary collaboration among intensivists, nephrologists, ICU nurses, pharmacists, and perfusion teams. These shifts favor suppliers that can combine reliable CRRT machines, hemofilters, dialysate and replacement fluids, disposables, digital monitoring, clinical education, and responsive technical service.

Cumulative Impact of Artificial Intelligence on CRRT

Artificial intelligence is beginning to influence Continuous Renal Replacement Therapy through predictive analytics, patient deterioration alerts, workflow automation, and decision-support tools that help clinicians identify AKI risk, fluid overload trends, electrolyte instability, anticoagulation challenges, and filter clotting patterns. The cumulative impact is not replacement of clinical judgment, but better visibility across high-acuity ICU data streams.

As hospitals digitize ICU operations, AI-enabled CRRT ecosystems may improve treatment consistency, reduce avoidable interruptions, support nursing efficiency, and guide inventory planning for fluids and disposables. Adoption will depend on clinically validated algorithms, explainable recommendations, cybersecurity, interoperability with electronic health records, and compliance with medical device software regulations.

Key Regional Insights Across the Global CRRT Landscape

North America remains a high-adoption region for Continuous Renal Replacement Therapy due to advanced ICU infrastructure, established nephrology-critical care collaboration, strong sepsis and AKI management protocols, and broad use in academic medical centers across the United States and Canada. Europe benefits from mature hospital procurement systems, evidence-based intensive care, and established renal replacement therapy pathways in Germany, France, Italy, Spain, and the United Kingdom, while the European Union's medical device framework increases emphasis on clinical safety, traceability, quality systems, and post-market surveillance.

Asia-Pacific is expanding as China, India, Japan, South Korea, and Australia invest in critical-care capacity, renal support access, clinician training, and tertiary hospital development. Latin America, led by Brazil and Mexico, shows demand from urban tertiary hospitals and private healthcare networks, though reimbursement variability and consumable costs influence adoption. The Middle East, especially GCC health systems, is upgrading ICU capability through hospital modernization, transplant programs, and specialist care investment, while Africa's CRRT opportunity is closely tied to critical-care infrastructure, specialist training, affordability, reliable electricity, water-quality management, and resilient supply chains for fluids and disposables.

Key Group Insights Shaping CRRT Demand

Within ASEAN, Continuous Renal Replacement Therapy demand is supported by expanding private hospitals, medical tourism, critical-care investment, and rising access to nephrology services, although workforce training, protocol standardization, and consumable affordability remain decisive. GCC countries are accelerating adoption through tertiary hospital expansion, transplant and cardiac programs, national healthcare modernization strategies, and investments in high-acuity care capacity.

The European Union emphasizes clinical quality, procurement discipline, regulatory compliance, and device traceability, while BRICS markets combine large AKI patient pools with uneven access, growing ICU investment, and rising interest in localized manufacturing and supply resilience. G7 countries represent advanced adoption, digital integration, premium technology demand, and strong clinical governance. NATO-aligned health systems also prioritize emergency preparedness, trauma response, surge capacity, and resilient supply chains for critical-care equipment, CRRT fluids, cartridges, and hemofilters.

Key Country Insights for CRRT Adoption

The United States leads in advanced CRRT utilization through large ICU networks, academic research activity, protocolized critical care, and established reimbursement pathways, while Canada emphasizes centralized procurement, provincial healthcare planning, and equitable access across hospital systems. Mexico and Brazil show expanding adoption in urban tertiary centers, with utilization influenced by public-private funding, trained ICU staff, nephrology availability, and consistent access to fluids, filters, and anticoagulation supplies.

In Europe, the United Kingdom, Germany, France, Italy, and Spain rely on evidence-led critical care, multidisciplinary renal support pathways, and structured hospital procurement, while Russia's demand is shaped by tertiary hospital capacity, regional access, and critical-care modernization. China and India represent high-volume opportunities driven by expanding ICUs, sepsis and AKI burden, cardiac care development, and hospital infrastructure growth. Japan and South Korea emphasize technologically advanced intensive care, aging-population needs, and strong clinical quality standards, while Australia supports steady demand through high-quality ICU practice, renal medicine expertise, and established critical-care networks.

Actionable Recommendations for CRRT Industry Leaders

Industry leaders should prioritize complete CRRT value propositions that combine reliable devices, hemofilters, dialysate and replacement fluids, anticoagulation compatibility, digital connectivity, safety features, and structured training. Hospitals need solutions that reduce therapy interruptions, simplify nursing workflows, support protocol adherence, improve fluid-balance accuracy, and maintain patient safety in high-acuity environments.

Manufacturers and suppliers should strengthen regional service networks, build resilient consumable supply chains, generate real-world clinical evidence, and align product development with ICU interoperability requirements. Commercial strategies should differentiate between premium mature markets, access-focused emerging markets, and public procurement environments where lifecycle cost, service uptime, supply assurance, and clinical education can be more persuasive than device features alone.

Research Methodology for CRRT Intelligence

A robust CRRT intelligence assessment should combine secondary research from peer-reviewed nephrology and critical-care literature, regulatory databases, hospital procurement disclosures, medical device filings, clinical guidelines, public health datasets, reimbursement references, and technology assessment documents. Primary validation should include interviews with nephrologists, intensivists, ICU nurses, procurement leaders, distributors, biomedical engineers, pharmacists, and renal therapy specialists.

Evidence synthesis should triangulate ICU bed capacity, AKI incidence, sepsis burden, cardiac surgery volumes, transplant activity, device installed base, consumable utilization patterns, reimbursement structures, training availability, and regional pricing indicators. Findings should be validated through cross-country benchmarking, scenario analysis, expert review, and evidence grading to ensure conclusions are clinically credible, operationally relevant, and commercially useful without relying on unsupported estimates.

Conclusion: Future of Continuous Renal Replacement Therapy

Continuous Renal Replacement Therapy is becoming a strategic pillar of modern intensive care as hospitals manage more complex AKI, sepsis, cardiac, trauma, transplant, and multi-organ failure cases. Adoption is strongest where ICU infrastructure, skilled teams, reimbursement, protocol maturity, and consumable logistics align, but access gaps remain significant in cost-sensitive and under-resourced settings.

The next phase of CRRT advancement will be shaped by integrated therapy platforms, digital monitoring, AI-supported decision tools, clinical training models, regulatory discipline, and resilient supply chains. Organizations that connect clinical outcomes with operational efficiency, service reliability, and evidence-based implementation will be best positioned in the global Continuous Renal Replacement Therapy landscape.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Continuous Renal Replacement Therapy Market, by Product Type

  • 7.1. CRRT Machines / Consoles
  • 7.2. Disposables
  • 7.3. Dialysate & Replacement Fluids

8. Continuous Renal Replacement Therapy Market, by Modality

  • 8.1. Hemodiafiltration
  • 8.2. Hemodialysis
  • 8.3. Hemofiltration
  • 8.4. Ultrafiltration

9. Continuous Renal Replacement Therapy Market, by Membrane Type

  • 9.1. High Flux Membranes
  • 9.2. Standard Flux Membranes

10. Continuous Renal Replacement Therapy Market, by Application

  • 10.1. Acute Kidney Injury (AKI)
  • 10.2. Chronic Kidney Disease (CKD)
  • 10.3. Drug Overdose & Poisoning
  • 10.4. Sepsis & Septic Shock

11. Continuous Renal Replacement Therapy Market, by End User

  • 11.1. Ambulatory Care Centers
  • 11.2. Hospitals
    • 11.2.1. Intensive Care Units
    • 11.2.2. Nephrology Departments

12. Continuous Renal Replacement Therapy Market, by Region

  • 12.1. Asia-Pacific
  • 12.2. North America
  • 12.3. Latin America
  • 12.4. Europe
  • 12.5. Middle East
  • 12.6. Africa

13. Continuous Renal Replacement Therapy Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Continuous Renal Replacement Therapy Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. Competitive Landscape

  • 15.1. Market Concentration Analysis, 2025
    • 15.1.1. Concentration Ratio (CR)
    • 15.1.2. Herfindahl Hirschman Index (HHI)
  • 15.2. Recent Developments & Impact Analysis, 2025
  • 15.3. Product Portfolio Analysis, 2025
  • 15.4. Benchmarking Analysis, 2025

16. Company Profiles

  • 16.1. Asahi Kasei Medical Co., Ltd.
  • 16.2. B. Braun Melsungen AG
  • 16.3. Baxter International Inc.
  • 16.4. Bellco S.r.l.
  • 16.5. Biolight Co., Ltd.
  • 16.6. Bioteque Corporation
  • 16.7. Cytosorbents Corporation
  • 16.8. Dialco Medical Inc.
  • 16.9. Fresenius Medical Care AG & Co. KGaA
  • 16.10. Genrui Biotech Co., Ltd.
  • 16.11. Getinge AB
  • 16.12. Infomed SA
  • 16.13. Jafron Biomedical Co., Ltd.
  • 16.14. JMS Co., Ltd.
  • 16.15. Kawasumi Laboratories, Inc.
  • 16.16. LivaNova
  • 16.17. Medica S.p.A.
  • 16.18. Medtronic plc
  • 16.19. Mindray Medical International Limited
  • 16.20. Nikkiso Co., Ltd.
  • 16.21. Nipro Corporation
  • 16.22. Outset Medical, Inc.
  • 16.23. Quanta Dialysis Technologies
  • 16.24. SWS Hemodialysis Care Co., Ltd.
  • 16.25. Terumo Corporation
  • 16.26. Toray Medical Co., Ltd.

LIST OF FIGURES

  • FIGURE 1. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET, YEARS CONSIDERED FOR THE STUDY
  • FIGURE 2. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET, RESEARCH DESIGN
  • FIGURE 3. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET, RESEARCH FRAMEWORK
  • FIGURE 4. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET, DATA TRIANGULATION
  • FIGURE 5. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 6. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 7. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 8. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2032 (%)
  • FIGURE 9. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2025 VS 2032 (%)
  • FIGURE 11. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MEMBRANE TYPE, 2025 VS 2032 (%)
  • FIGURE 13. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MEMBRANE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
  • FIGURE 15. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 16. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2025 VS 2032 (%)
  • FIGURE 17. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 18. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY REGION, 2025 VS 2032 (%)
  • FIGURE 19. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 20. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
  • FIGURE 21. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 22. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
  • FIGURE 23. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL CRRT MACHINES / CONSOLES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL CRRT MACHINES / CONSOLES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL CRRT MACHINES / CONSOLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL DISPOSABLES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL DISPOSABLES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL DISPOSABLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL DIALYSATE & REPLACEMENT FLUIDS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL DIALYSATE & REPLACEMENT FLUIDS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL DIALYSATE & REPLACEMENT FLUIDS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL HEMODIAFILTRATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL HEMODIAFILTRATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL HEMODIAFILTRATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL HEMODIALYSIS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL HEMODIALYSIS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL HEMODIALYSIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL HEMOFILTRATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL HEMOFILTRATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL HEMOFILTRATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL ULTRAFILTRATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL ULTRAFILTRATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL ULTRAFILTRATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MEMBRANE TYPE, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL HIGH FLUX MEMBRANES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL HIGH FLUX MEMBRANES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL HIGH FLUX MEMBRANES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL STANDARD FLUX MEMBRANES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL STANDARD FLUX MEMBRANES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL STANDARD FLUX MEMBRANES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL ACUTE KIDNEY INJURY (AKI) MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL ACUTE KIDNEY INJURY (AKI) MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL ACUTE KIDNEY INJURY (AKI) MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL CHRONIC KIDNEY DISEASE (CKD) MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL CHRONIC KIDNEY DISEASE (CKD) MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL CHRONIC KIDNEY DISEASE (CKD) MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL DRUG OVERDOSE & POISONING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL DRUG OVERDOSE & POISONING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL DRUG OVERDOSE & POISONING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL SEPSIS & SEPTIC SHOCK MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL SEPSIS & SEPTIC SHOCK MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL SEPSIS & SEPTIC SHOCK MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL AMBULATORY CARE CENTERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL AMBULATORY CARE CENTERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL AMBULATORY CARE CENTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL HOSPITALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL HOSPITALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL HOSPITALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL INTENSIVE CARE UNITS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL INTENSIVE CARE UNITS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL INTENSIVE CARE UNITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL NEPHROLOGY DEPARTMENTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL NEPHROLOGY DEPARTMENTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL NEPHROLOGY DEPARTMENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. ASIA-PACIFIC CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 60. ASIA-PACIFIC CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 61. ASIA-PACIFIC CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 62. ASIA-PACIFIC CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MEMBRANE TYPE, 2018-2032 (USD MILLION)
  • TABLE 63. ASIA-PACIFIC CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 64. ASIA-PACIFIC CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 65. ASIA-PACIFIC CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 66. NORTH AMERICA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 67. NORTH AMERICA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 68. NORTH AMERICA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 69. NORTH AMERICA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MEMBRANE TYPE, 2018-2032 (USD MILLION)
  • TABLE 70. NORTH AMERICA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 71. NORTH AMERICA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 72. NORTH AMERICA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 73. LATIN AMERICA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 74. LATIN AMERICA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 75. LATIN AMERICA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 76. LATIN AMERICA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MEMBRANE TYPE, 2018-2032 (USD MILLION)
  • TABLE 77. LATIN AMERICA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 78. LATIN AMERICA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 79. LATIN AMERICA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 80. EUROPE CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 81. EUROPE CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 82. EUROPE CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 83. EUROPE CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MEMBRANE TYPE, 2018-2032 (USD MILLION)
  • TABLE 84. EUROPE CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 85. EUROPE CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 86. EUROPE CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 87. MIDDLE EAST CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 88. MIDDLE EAST CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 89. MIDDLE EAST CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 90. MIDDLE EAST CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MEMBRANE TYPE, 2018-2032 (USD MILLION)
  • TABLE 91. MIDDLE EAST CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 92. MIDDLE EAST CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 93. MIDDLE EAST CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 94. AFRICA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 95. AFRICA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 96. AFRICA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 97. AFRICA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MEMBRANE TYPE, 2018-2032 (USD MILLION)
  • TABLE 98. AFRICA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 99. AFRICA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 100. AFRICA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 102. ASEAN CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 103. ASEAN CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 104. ASEAN CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 105. ASEAN CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MEMBRANE TYPE, 2018-2032 (USD MILLION)
  • TABLE 106. ASEAN CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 107. ASEAN CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 108. ASEAN CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 109. GCC CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 110. GCC CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 111. GCC CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 112. GCC CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MEMBRANE TYPE, 2018-2032 (USD MILLION)
  • TABLE 113. GCC CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 114. GCC CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 115. GCC CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 116. EUROPEAN UNION CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 117. EUROPEAN UNION CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 118. EUROPEAN UNION CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 119. EUROPEAN UNION CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MEMBRANE TYPE, 2018-2032 (USD MILLION)
  • TABLE 120. EUROPEAN UNION CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 121. EUROPEAN UNION CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 122. EUROPEAN UNION CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 123. BRICS CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 124. BRICS CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 125. BRICS CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 126. BRICS CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MEMBRANE TYPE, 2018-2032 (USD MILLION)
  • TABLE 127. BRICS CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 128. BRICS CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 129. BRICS CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 130. G7 CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 131. G7 CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 132. G7 CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 133. G7 CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MEMBRANE TYPE, 2018-2032 (USD MILLION)
  • TABLE 134. G7 CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 135. G7 CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 136. G7 CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 137. NATO CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 138. NATO CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 139. NATO CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 140. NATO CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MEMBRANE TYPE, 2018-2032 (USD MILLION)
  • TABLE 141. NATO CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 142. NATO CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 143. NATO CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 144. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 145. UNITED STATES CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 146. UNITED STATES CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 147. UNITED STATES CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 148. UNITED STATES CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MEMBRANE TYPE, 2018-2032 (USD MILLION)
  • TABLE 149. UNITED STATES CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 150. UNITED STATES CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 151. UNITED STATES CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 152. CANADA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 153. CANADA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 154. CANADA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 155. CANADA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MEMBRANE TYPE, 2018-2032 (USD MILLION)
  • TABLE 156. CANADA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 157. CANADA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 158. CANADA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 159. MEXICO CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 160. MEXICO CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 161. MEXICO CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 162. MEXICO CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MEMBRANE TYPE, 2018-2032 (USD MILLION)
  • TABLE 163. MEXICO CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 164. MEXICO CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 165. MEXICO CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 166. BRAZIL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 167. BRAZIL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 168. BRAZIL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 169. BRAZIL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MEMBRANE TYPE, 2018-2032 (USD MILLION)
  • TABLE 170. BRAZIL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 171. BRAZIL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 172. BRAZIL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 173. UNITED KINGDOM CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 174. UNITED KINGDOM CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 175. UNITED KINGDOM CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 176. UNITED KINGDOM CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MEMBRANE TYPE, 2018-2032 (USD MILLION)
  • TABLE 177. UNITED KINGDOM CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 178. UNITED KINGDOM CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 179. UNITED KINGDOM CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 180. GERMANY CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 181. GERMANY CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 182. GERMANY CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 183. GERMANY CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MEMBRANE TYPE, 2018-2032 (USD MILLION)
  • TABLE 184. GERMANY CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 185. GERMANY CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 186. GERMANY CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 187. FRANCE CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 188. FRANCE CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 189. FRANCE CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 190. FRANCE CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MEMBRANE TYPE, 2018-2032 (USD MILLION)
  • TABLE 191. FRANCE CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 192. FRANCE CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 193. FRANCE CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 194. RUSSIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 195. RUSSIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 196. RUSSIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 197. RUSSIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MEMBRANE TYPE, 2018-2032 (USD MILLION)
  • TABLE 198. RUSSIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 199. RUSSIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 200. RUSSIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 201. ITALY CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 202. ITALY CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 203. ITALY CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 204. ITALY CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MEMBRANE TYPE, 2018-2032 (USD MILLION)
  • TABLE 205. ITALY CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 206. ITALY CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 207. ITALY CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 208. SPAIN CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 209. SPAIN CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 210. SPAIN CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 211. SPAIN CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MEMBRANE TYPE, 2018-2032 (USD MILLION)
  • TABLE 212. SPAIN CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 213. SPAIN CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 214. SPAIN CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 215. CHINA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 216. CHINA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 217. CHINA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 218. CHINA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MEMBRANE TYPE, 2018-2032 (USD MILLION)
  • TABLE 219. CHINA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 220. CHINA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 221. CHINA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 222. INDIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 223. INDIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 224. INDIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 225. INDIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MEMBRANE TYPE, 2018-2032 (USD MILLION)
  • TABLE 226. INDIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 227. INDIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 228. INDIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 229. JAPAN CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 230. JAPAN CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 231. JAPAN CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 232. JAPAN CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MEMBRANE TYPE, 2018-2032 (USD MILLION)
  • TABLE 233. JAPAN CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 234. JAPAN CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 235. JAPAN CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 236. AUSTRALIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 237. AUSTRALIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 238. AUSTRALIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 239. AUSTRALIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MEMBRANE TYPE, 2018-2032 (USD MILLION)
  • TABLE 240. AUSTRALIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 241. AUSTRALIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 242. AUSTRALIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 243. SOUTH KOREA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 244. SOUTH KOREA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 245. SOUTH KOREA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 246. SOUTH KOREA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MEMBRANE TYPE, 2018-2032 (USD MILLION)
  • TABLE 247. SOUTH KOREA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 248. SOUTH KOREA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 249. SOUTH KOREA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)